Acrivon Therapeutics ACRV Cash Flow Statement (2021-2026)

NASDAQ ACRV
$2.20 -0.19 (-7.95%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter) -2.67M-6.28M-7.21M-5.92M-15.93M-10.24M-35.11M-35.02M-28.28M-21.35M-27.10M-26.44M-33.69M-25.45M-25.61M-23.05M-20.18M-21.17M-22.51M-20.93M
Depreciation and Depletion (Quarter) 0.01M0.01M0.04M0.10M0.10M0.16M0.12M0.10M0.10M0.15M0.22M0.20M0.30M0.30M0.30M0.30M0.30M0.41M0.40M0.40M
Share-based Compensation (Quarter) 0.03M-5.70M0.04M0.23M0.27M1.65M2.65M2.69M3.23M3.06M3.34M3.57M3.67M14.23M3.79M3.93M12.70M3.09M2.18M2.21M
Cash from Operations (Quarter) -3.63M-8.42M-5.82M-6.52M-9.35M-11.36M-9.11M-9.81M-12.37M-17.08M-13.90M-17.32M-17.36M-19.54M-16.61M-12.28M-15.24M-20.54M-14.86M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.52M1.13M0.77M0.74M0.68M0.58M1.10M1.20M0.90M0.36M0.17M0.03M-0.13M-0.16M-0.06M
Depreciation & Amortization (CF) (Quarter) 0.01M0.01M0.04M0.10M0.10M0.16M0.12M0.10M0.10M0.15M0.22M0.20M0.30M0.30M0.30M0.30M0.30M0.41M0.40M0.40M
Change in Working Capital
Change in Account Payables (Quarter) 0.30M-0.10M0.54M0.03M-0.73M0.47M-0.11M0.08M3.17M-2.27M-0.94M-0.14M-0.23M2.82M-2.55M-0.01M1.28M-1.20M-0.21M
Change in Accured Expenses (Quarter) 1.00M-0.33M0.74M0.98M1.53M-1.32M1.43M2.02M1.04M-1.48M2.87M3.46M3.18M-7.00M2.15M1.97M-0.48M-3.38M0.71M
Other Working Capital Changes (Quarter) 0.63M0.88M1.61M-1.45M2.50M-0.59M-1.42M0.07M-0.17M-0.14M-0.27M-0.29M0.47M-0.47M-0.70M0.22M0.76M-0.38M0.05M
Investing Activities
Capital Expenditures (Quarter) 0.14M0.41M1.07M0.43M0.25M0.03M0.11M1.15M0.81M0.14M0.23M0.06M0.49M0.90M0.22M0.01M0.09M
Change in Acquisitions & Divestments (Quarter) 6.00M26.32M19.45M24.50M38.27M35.00M46.92M22.00M50.00M39.50M35.00M40.00M35.00M30.00M25.00M
Cash from Investing Activities (Quarter) -0.14M-0.41M-1.07M-45.12M-95.07M9.33M19.34M1.52M20.54M5.85M-88.04M16.01M14.41M19.21M19.45M5.91M21.52M13.13M14.95M
Financing Activities
Other financing activities (Quarter) 0.08M0.32M0.08M0.01M69.91M0.00M0.01M
Cash from Financing Activities (Quarter) 99.75M-0.14M101.86M0.08M-2.01M-0.17M123.35M-1.50M-0.65M-0.34M-0.10M-0.12M-0.19M-0.03M7.27M
Additional items
Change in Cash (Quarter) 95.99M-8.83M-6.91M-51.78M-2.56M-2.03M10.61M-8.21M6.16M-11.40M21.40M-2.82M-3.60M-0.66M2.74M-6.49M6.09M-7.44M7.35M
Free Cash Flow (Quarter) -3.76M-8.83M-6.90M-6.95M-9.61M-11.38M-9.22M-9.81M-13.52M-17.90M-14.04M-17.55M-17.36M-19.59M-17.10M-13.18M-15.46M-20.55M-14.95M
Net Cash Flow (Quarter) 95.99M-8.83M-6.90M-51.78M-2.56M-2.03M10.23M-8.21M6.16M-11.40M21.40M-2.82M-3.60M-0.66M2.74M-6.49M6.09M-7.44M7.35M